Sex and Age Differences in a Progressive Synucleinopathy Mouse Model.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
11 06 2023
Historique:
received: 12 04 2023
revised: 22 05 2023
accepted: 02 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

The mutation and overexpression of the alpha-synuclein protein (αSyn), described as synucleinopathy, is associated with Parkinson's disease (PD)-like pathologies. A higher prevalence of PD is documented for men versus women, suggesting female hormones' implication in slowing PD progression. The nigrostriatal dopamine (DA) neurons in rodent males are more vulnerable to toxins than those in females. The effect of biological sex on synucleinopathy remains poorly described and was investigated using mice knocked out for murine αSyn (SNCA-/-) and also overexpressing human αSyn (SNCA-OVX) compared to wildtype (WT) mice. All the mice showed decreased locomotor activity with age, and more abruptly in the male than in the female SNCA-OVX mice; anxiety-like behavior increased with age. The SNCA-OVX mice had an age-dependent accumulation of αSyn. Older age was associated with the loss of nigral DA neurons and decreased striatal DA contents. The astrogliosis, microgliosis, and cytokine concentrations increased with aging. More abrupt nigrostriatal DA decreases and increased microgliosis were observed in the male SNCA-OVX mice. Human αSyn overexpression and murine αSyn knockout resulted in behavioral dysfunctions, while only human αSyn overexpression was toxic to DA neurons. At 18 months, neuroprotection was lost in the female SNCA-OVX mice, with a likely loss of estrus cycles. In conclusion, sex-dependent αSyn toxicity was observed, affecting the male mice more significantly.

Identifiants

pubmed: 37371557
pii: biom13060977
doi: 10.3390/biom13060977
pmc: PMC10296285
pii:
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-159680
Pays : Canada
Organisme : CIHR
ID : SVB-158621
Pays : Canada

Références

Nat Protoc. 2007;2(1):141-51
pubmed: 17401348
Neurosci Biobehav Rev. 2016 Aug;67:79-88
pubmed: 26708712
Brain. 1999 Aug;122 ( Pt 8):1437-48
pubmed: 10430830
Science. 1996 Nov 15;274(5290):1197-9
pubmed: 8895469
Neurology. 1988 Aug;38(8):1285-91
pubmed: 3399080
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):637-9
pubmed: 15026515
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Neuroimmunomodulation. 2011;18(2):79-88
pubmed: 20938211
J Parkinsons Dis. 2015;5(4):699-713
pubmed: 26407041
Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12571-2
pubmed: 19666621
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E4016-25
pubmed: 24082145
Neurotherapeutics. 2012 Apr;9(2):297-314
pubmed: 22350713
Acta Neuropathol. 2012 May;123(5):653-69
pubmed: 22361813
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Methods Mol Biol. 2012;849:347-59
pubmed: 22528101
Int J Mol Sci. 2021 Jun 17;22(12):
pubmed: 34204581
Mov Disord. 2017 Jan;32(1):94-105
pubmed: 27873359
Lancet. 1995 Sep 30;346(8979):861-4
pubmed: 7564669
Biol Reprod. 1981 May;24(4):784-94
pubmed: 7195743
Brain. 2013 Aug;136(Pt 8):2419-31
pubmed: 23884810
Front Neuroendocrinol. 2014 Aug;35(3):370-84
pubmed: 24607323
J Biol Chem. 2010 Mar 19;285(12):9262-72
pubmed: 20071342
Neuroscience. 2003;116(1):213-22
pubmed: 12535954
Front Pharmacol. 2021 May 20;12:644103
pubmed: 34093183
Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9
pubmed: 15451224
J Steroid Biochem Mol Biol. 2016 Jun;160:127-33
pubmed: 26435451
J Neuroinflammation. 2021 Sep 22;18(1):219
pubmed: 34551810
Neurology. 2008 Jan 1;70(1):43-9
pubmed: 17625105
J Neuroinflammation. 2012 Nov 27;9:259
pubmed: 23186369
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8284-E8293
pubmed: 28900002
J Neurol. 2012 Aug;259(8):1639-47
pubmed: 22237822
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Front Pharmacol. 2019 Sep 12;10:1008
pubmed: 31572186
Brain. 2010 Jul;133(Pt 7):2032-44
pubmed: 20534649
Int J Mol Sci. 2019 Dec 11;20(24):
pubmed: 31835787
Front Behav Neurosci. 2013 Nov 26;7:175
pubmed: 24324416
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Brain. 2019 Jun 1;142(6):1690-1700
pubmed: 31056668
J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):952-7
pubmed: 26701996
J Parkinsons Dis. 2015;5(1):1-19
pubmed: 25588354
Pharmacol Rep. 2017 Apr;69(2):242-251
pubmed: 28126640
Neuropharmacology. 2021 Dec 15;201:108784
pubmed: 34555366
J Neurochem. 2019 Sep;150(5):475-486
pubmed: 31269263
Pharmaceuticals (Basel). 2023 Jan 20;16(2):
pubmed: 37259303
J Neurosci. 2002 Apr 1;22(7):2780-91
pubmed: 11923443
Exp Neurol. 2018 Mar;301(Pt A):39-49
pubmed: 29229294
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Neurol Neurochir Pol. 2014;48(5):322-7
pubmed: 25440010
Nutrients. 2021 Nov 24;13(12):
pubmed: 34959768
Neurology. 2008 Jan 1;70(1):7-9
pubmed: 18166703
Science. 2010 Sep 24;329(5999):1663-7
pubmed: 20798282
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):905-6
pubmed: 17635983
J Vis Exp. 2015 Feb 06;(96):e52434
pubmed: 25742564
Glia. 2013 Mar;61(3):349-60
pubmed: 23108585
Psychoneuroendocrinology. 2011 Aug;36(7):955-69
pubmed: 21236583
Front Aging Neurosci. 2021 Oct 25;13:757714
pubmed: 34759815
J Neurosci. 2019 Sep 18;39(38):7628-7640
pubmed: 31405930
Nat Rev Neurol. 2013 Jan;9(1):13-24
pubmed: 23183883
J Neurochem. 2015 Nov;135(3):589-97
pubmed: 26201615
Neurobiol Aging. 2008 Apr;29(4):574-85
pubmed: 17174013
Ann Neurol. 2012 Oct;72(4):517-24
pubmed: 23109146
Mov Disord. 2021 Oct;36(10):2264-2272
pubmed: 34426982
Mov Disord. 2009 Aug 15;24(11):1641-9
pubmed: 19514014
Mol Endocrinol. 2007 Jun;21(6):1281-96
pubmed: 17374850
Front Cell Neurosci. 2021 Apr 15;15:658244
pubmed: 33935654
PLoS One. 2016 Sep 13;11(9):e0162717
pubmed: 27622765
Neurobiol Dis. 2009 May;34(2):279-90
pubmed: 19385059
Neurobiol Aging. 2016 Dec;48:61-71
pubmed: 27644075
Brain Res. 2002 Nov 22;956(1):30-5
pubmed: 12426043
Ann Neurol. 2010 Jun;67(6):715-25
pubmed: 20517933
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
Mov Disord. 2021 Dec;36(12):2888-2900
pubmed: 34494685
Biol Reprod. 1982 Sep;27(2):327-39
pubmed: 6889895
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):819-24
pubmed: 17098842
J Steroid Biochem Mol Biol. 2017 Nov;174:242-256
pubmed: 28982631
Cells. 2020 Jul 14;9(7):
pubmed: 32674367

Auteurs

Jérôme Lamontagne-Proulx (J)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.
Laboratoire International Associé OptiNutriBrain (NutriNeuro France-INAF Canada), Québec, QC G1V 0A6, Canada.

Katherine Coulombe (K)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.

Marc Morissette (M)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.

Marie Rieux (M)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.

Frédéric Calon (F)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.
Laboratoire International Associé OptiNutriBrain (NutriNeuro France-INAF Canada), Québec, QC G1V 0A6, Canada.
Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Université Laval, 2440, Boulevard Hochelaga, Bureau 1705, Québec, QC G1V 0A6, Canada.

Thérèse Di Paolo (T)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.
Laboratoire International Associé OptiNutriBrain (NutriNeuro France-INAF Canada), Québec, QC G1V 0A6, Canada.

Denis Soulet (D)

Centre de Recherche du CHU de Québec, Axe Neurosciences, T2-32, 2705, Boulevard Laurier, Québec, QC G1V 4G2, Canada.
Laboratoire International Associé OptiNutriBrain (NutriNeuro France-INAF Canada), Québec, QC G1V 0A6, Canada.
Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Université Laval, 2440, Boulevard Hochelaga, Bureau 1705, Québec, QC G1V 0A6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH